GETWAB

02 / Federal Business Size

Federal contract market at a glance

Measured consistently across FY 2019–FY 2025.

Net obligations$305.40M
Contract actions28
Awards / PIIDs6
Federal customers2
Contracting offices3
Average action$10.91M
Active fiscal years7
Data coverageFY 2019–FY 2025

Across FY 2019–FY 2025, FPDS records attribute $305.40M in net contract obligations to EMERGENT BIODEFENSE OPERATIONS LANSING LLC across 28 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.

03 / Spending Trend

EMERGENT BIODEFENSE OPERATIONS LANSING LLC contract spending by year

Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.

Total obligations$20.80M
FY 2025
ObligationsHistorical spending range
Fiscal yearObligationsActionsFederal customersChange
FY 2019$172.93M61
FY 2020$60.17M51−65.2%
FY 2021$021−100.0%
FY 2022$30.52M71
FY 2023-$10.5K11−100.0%
FY 2024$21.00M31+200,987.8%
FY 2025$20.80M41−0.9%

04 / Federal Customers

Which federal agencies buy from EMERGENT BIODEFENSE OPERATIONS LANSING LLC?

Ranked by net obligations during FY 2019–FY 2025.

AgencyCodeObligationsActionsVendor share
7505$263.60M2186.3%
2100$41.80M713.7%

05 / Contracting Offices

Which contracting offices buy from EMERGENT BIODEFENSE OPERATIONS LANSING LLC?

Ranked by net obligations during FY 2019–FY 2025.

06 / Top NAICS Industries

Which industries define this vendor’s federal work?

NAICSDescriptionObligationsActionsCustomersShare
325414BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING$254.28M16183.3%
325411MEDICINAL AND BOTANICAL MANUFACTURING$41.80M7113.7%
541711RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY$9.18M213.0%
325412PHARMACEUTICAL PREPARATION MANUFACTURING$135.9K210.0%
541380TESTING LABORATORIES$0110.0%

07 / Top Product and Service Codes

What products and services does the government buy from this vendor?

PSCDescriptionObligationsActionsCustomersShare
6505DRUGS AND BIOLOGICALS$296.22M25297.0%
C118RESEARCH AND DEVELOPMENT FACILITIES$9.18M213.0%
Q301MEDICAL- LABORATORY TESTING$0110.0%

08 / Competition Pattern

How was EMERGENT BIODEFENSE OPERATIONS LANSING LLC’s federal work competed?

Competition categories describe the procurement path recorded on the underlying contract actions.

Competition categoryObligationsActions
Not available for competition$254.42M18
Not competed$41.80M7
Competed$9.18M2
Other / unknown$01

09 / Recent Contract Awards

What contract actions were recorded most recently for EMERGENT BIODEFENSE OPERATIONS LANSING LLC?

The latest recorded PIIDs connect this profile to the underlying federal award search.

Award / PIIDSignedObligationAgency / officeNAICSPSC
W911SR24F0016Sep 17, 2025$0DEPT OF THE ARMY W6QK ACC-APG3254116505

10 / Interpreting the Profile

How should you evaluate EMERGENT BIODEFENSE OPERATIONS LANSING LLC as a federal contractor?

Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.

01

Separate obligations from revenue

FPDS obligations are government accounting actions and may include later deobligations.

02

Follow customer concentration

Agency and office concentration reveals where the vendor’s federal relationships are strongest.

03

Test market overlap

NAICS and PSC shares show whether the vendor competes in the same markets as your company.

04

Inspect the awards

Open the PIIDs to verify dates, offices, classifications, and transaction history.